Detalles de la búsqueda
1.
A network meta-analysis of efficacy and safety for first-line and second/further-line therapies in postmenopausal women with hormone receptor-positive, HER2-negative, advanced breast cancer.
BMC Med
; 22(1): 13, 2024 01 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38212842
2.
Identifying optimal ALK inhibitors in first- and second-line treatment of patients with advanced ALK-positive non-small-cell lung cancer: a systematic review and network meta-analysis.
BMC Cancer
; 24(1): 186, 2024 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38331773
3.
Is it time for China to prioritize pan-genotypic regimens for treating patients with hepatitis C?
Cost Eff Resour Alloc
; 22(1): 11, 2024 Feb 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38321475
4.
QALY-type preference and willingness-to-pay among end-of-life patients with cancer treatments: a pilot study using discrete choice experiment.
Qual Life Res
; 33(3): 753-765, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38079024
Resultados
1 -
4
de 4
1
Próxima >
>>